NEWS
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
The Top-50 biopharmaceutical investors in the world.
Category: Health
The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D.
The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn in research and development – approximately 19% of the global estimate. The sector is the one of the most research-intensive in the world. Sixteen of the Top-50 innovative companies in the world are drugmakers.
Here is the list of the Top-fifty biopharmaceutical investors in the world
Source: Health Informatics